Document is current
Any future updates will be listed below
-
Authors
Jouwena, Jennifer https://orcid.org/0000-0003-1862-4041
Eerlings, Sarah A.
De Wolf, Andre M.
Van Hoovels, Lieve
Neyrinck, Arne
Van de Velde, Marc
Hendrickx, Jan F. A.
- License Information
-
More Information
Article History
Received: 8 February 2022
Accepted: 4 July 2022
First Online: 27 July 2022
Declarations
:
: Jan Hendrickx has received lecture support, travel reimbursements, equipment loans, consulting fees and/or meeting organizational support from a number of companies involved with inhaled agent delivery (alphabetically): AbbVie, Acertys, Air Liquide, Allied Healthcare, Armstrong Medical, Baxter, Dräger, GE, Hospithera, Heinen und Löwenstein, Intersurgical, Maquet, MDMS, MEDEC, Micropore, Molecular, NWS, Philips, Quantum Medical. The other authors declare that they have no conflict of interest.
: Approval was granted by the Ethics Committee of OLV hospital. This study was performed in line with the principles of the Declaration of Helsinki. Belgian Registration Number B126202042718; Local Hospital Number 2020/009.
: Informed consent was obtained from all individual participants included in the study.
